Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The combination of zolbetuximab plus chemotherapy produced one of the longest overall survival outcomes ever seen for patients with advanced caludin18.2+ gastric or gastroesophageal junction cancer.
Although guidelines recommend stopping cervical screening for women 65 and over, this age group accounts for one fifth of diagnoses, more late-stage disease, and higher mortality.
After 2 years of supplementation, those with higher BMIs show lower increases in vitamin D biomarkers versus those of normal weight, possibly explaining reduced clinical benefits from the supplementation.
After years of controversy, both skeptics and proponents of the REDUCE-IT study findings agree that a new trial may be desirable, but unlikely to happen.
The eventual goal: a simple test to help determine who has long COVID and whether treatments are helping.